Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Changes in PCSK 9 and apolipoprotein B100 in Niemann–Pick disease after enzyme replacement therapy with olipudase alfa

Fig. 1

Percentages changes in variables from baseline to week 26. a Mean percentage changes in lipid profile from baseline to week 26. b Mean percentage changes in apoB-100 and apoB-48 from baseline to week 26. c Mean percentage changes in HDL-C, apoAI and cholesterol efflux capacity from baseline to week 26. d Mean percentage change in TNFα from baseline to week 26. Absolute values and standard deviations at baseline and week 26 are shown in Table 2. Abbreviations: apoAI, apolipoprotein A-I; apoB-100, apolipoprotein B-100; apoB-48, apolipoprotein B-48; HDL-C, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; sdLDL, small dense low-density lipoprotein; TG, triglyceride; TNFα, tumour necrosis factor alpha

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172